ストックスクリーナーアプリを入手
515.55
0.24%
1.22
アフターアワーズ：
515.55
前日終値:
$514.33
開ける：
$518.07
24時間の取引高:
362.29K
Relative Volume:
0.45
時価総額：
$41.46B
収益：
$3.93B
当期純損益:
$894.97M
株価収益率:
47.65
EPS:
10.82
ネットキャッシュフロー:
$837.70M
1週間 パフォーマンス:
+2.12%
1か月 パフォーマンス:
+17.98%
6か月 パフォーマンス:
+22.24%
1年 パフォーマンス:
+3.45%
1日の値動き範囲:
$510.64
$520.00
1週間の範囲:
$496.61
$520.00
52週間の値動き範囲:
$356.14
$530.60
Idexx Laboratories Inc Stock (IDXX) Company Profile
名前
Idexx Laboratories Inc
セクター
電話
(207) 556-0300
住所
ONE IDEXX DRIVE, WESTBROOK, ME
IDXX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
515.55 | 40.60B | 3.93B | 894.97M | 837.70M | 10.82 |
|
TMO
Thermo Fisher Scientific Inc
|
403.75 | 151.18B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
190.47 | 134.17B | 23.82B | 3.77B | 4.90B | 5.15 |
|
A
Agilent Technologies Inc
|
113.28 | 31.27B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
141.02 | 23.88B | 15.50B | 1.33B | 2.16B | 7.34 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-02 | 開始されました | Leerink Partners | Outperform |
| 2024-07-25 | 開始されました | BTIG Research | Buy |
| 2024-01-30 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2023-12-07 | 開始されました | Exane BNP Paribas | Outperform |
| 2023-12-04 | アップグレード | Cleveland Research | Neutral → Buy |
| 2023-08-02 | ダウングレード | Atlantic Equities | Overweight → Neutral |
| 2022-07-25 | ダウングレード | Stifel | Buy → Hold |
| 2022-07-21 | アップグレード | Goldman | Neutral → Buy |
| 2022-07-12 | 開始されました | Piper Sandler | Overweight |
| 2022-05-05 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-02-08 | 開始されました | Atlantic Equities | Overweight |
| 2021-11-18 | 開始されました | Morgan Stanley | Overweight |
| 2021-08-05 | 再開されました | Credit Suisse | Outperform |
| 2021-07-12 | ダウングレード | Guggenheim | Buy → Neutral |
| 2021-02-17 | 開始されました | Barclays | Overweight |
| 2019-09-09 | 開始されました | Goldman | Neutral |
| 2019-05-23 | 開始されました | Guggenheim | Buy |
| 2018-11-02 | 繰り返されました | BofA/Merrill | Buy |
| 2018-05-07 | 繰り返されました | Stifel | Buy |
| 2018-01-16 | 開始されました | Piper Jaffray | Overweight |
| 2017-08-23 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2017-07-28 | アップグレード | CL King | Neutral → Buy |
| 2017-02-03 | ダウングレード | Feltl & Co. | Hold → Sell |
| 2016-09-29 | 再開されました | BofA/Merrill | Neutral |
| 2016-08-16 | 繰り返されました | Stifel | Buy |
| 2016-08-03 | アップグレード | Northcoast | Sell → Neutral |
| 2016-07-20 | 繰り返されました | Canaccord Genuity | Buy |
| 2016-04-19 | 繰り返されました | Canaccord Genuity | Buy |
| 2016-04-01 | 開始されました | CL King | Neutral |
| 2016-03-21 | 繰り返されました | Stifel | Buy |
| 2016-02-04 | 開始されました | Credit Suisse | Outperform |
| 2015-10-29 | 繰り返されました | Stifel | Buy |
| 2015-08-28 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2015-08-13 | 繰り返されました | Stifel | Buy |
| 2015-07-23 | 繰り返されました | Canaccord Genuity | Buy |
すべてを表示
Idexx Laboratories Inc (IDXX) 最新ニュース
Companion Animal Diagnostics Market Is Booming WorldwideIDEXX Laboratories, Heska Corporation - openPR.com
Transcript : IDEXX Laboratories, Inc. Presents at Stifel Jaws & Paws Conference 2025, May-28-2025 10 - marketscreener.com
IDEXX Laboratories To Present At Stifel Jaws & Paws Conference; Webcast At 10:55 AM ET - Nasdaq
IDEXX Laboratories Stock: Analyst Estimates & Ratings - MSN
IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Stock's On An Uptrend: Are Strong Financials Guiding The Market? - simplywall.st
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
IDEXX Lab jumps after Q1 beat and guidance raise - MSN
IDEXX Laboratories (NASDAQ:IDXX) Given New $510.00 Price Target at Stifel Nicolaus - Defense World
IDEXX Laboratories (IDXX) Target Price Raised by Stifel to $510 | IDXX Stock News - GuruFocus
If You Invested $1000 in Idexx Laboratories a Decade Ago, This is How Much It'd Be Worth Now - Yahoo Finance
Idexx Laboratories (IDXX) Price Target Increased by Stifel Analy - GuruFocus
Stifel Adjusts Price Target on IDEXX Laboratories to $510 From $460, Maintains Hold Rating - marketscreener.com
5 High-Flying Medical Instrument Stocks to Buy Despite Recent Turmoil - TradingView
IDEXX Laboratories: Growth Remains Despite Weak Clinical Visits (NASDAQ:IDXX) - Seeking Alpha
Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year? - Yahoo Finance
IDEXX Laboratories to Present at Stifel Conference and Announces 2025 Investor Day | IDXX Stock News - GuruFocus
IDEXX Laboratories to Present at Stifel Conference and Announces 2025 Investor Day - Business Wire
BNP Paribas Exane Adjusts Price Target on IDEXX Laboratories to $577 From $566, Maintains Outperform Rating - marketscreener.com
IDEXX Laboratories (NASDAQ:IDXX) Upgraded at StockNews.com - Defense World
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Stocks Shoot Up 26% But Its P/E Still Looks Reasonable - simplywall.st
Idexx outlines 2025 growth with 6-9% organic revenue target amid innovation launches - MSN
IDEXX Laboratories (IDXX) Announces Key Amendments to Corporate Structure - GuruFocus
IDEXX Laboratories Updates Corporate Governance Structure - TipRanks
Here’s Why Baron Focused Growth Fund Invested in IDEXX Laboratories (IDXX) - Insider Monkey
IDEXX Laboratories (NASDAQ:IDXX) Price Target Raised to $558.00 at Morgan Stanley - Defense World
Rep. April McClain Delaney Buys IDEXX Laboratories, Inc. (NASDAQ:IDXX) Stock - Defense World
IDEXX Laboratories (IDXX) Target Price Raised by Morgan Stanley | IDXX Stock News - GuruFocus
BTIG Raises Price Target on IDEXX Laboratories to $545 From $530, Maintains Buy Rating - marketscreener.com
Morgan Stanley Adjusts Price Target on IDEXX Laboratories to $558 From $548, Maintains Overweight Rating - marketscreener.com
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q1 2025 Earnings Call Transcript - Insider Monkey
IDEXX Laboratories Ups Profit Forecast Thanks To Pet Care Demand - Finimize
IDEXX Laboratories [NasdaqGS:IDXX] Raises 2025 Guidance and Reports Q1 Growth in Revenue and EPS - Yahoo Finance
Leerink Partners Adjusts IDEXX Laboratories Price Target to $515 From $500 - marketscreener.com
IDEXX Laboratories Announces First Quarter Results | IDXX Stock News - GuruFocus
IDEXX Laboratories (IDXX) Surpasses Q1 Expectations with Robust Earnings - GuruFocus
IDEXX Laboratories Inc (IDXX) Q1 2025 Earnings Call Highlights: Strong Organic Growth Amid ... - Yahoo
IDEXX Laboratories Inc (IDXX) Q1 2025 Earnings Call Highlights: Strong Organic Growth Amid Market Challenges - GuruFocus
IDEXX Laboratories Reports Strong Q1 2025 Results - TipRanks
Idexx: Q1 Earnings Snapshot - CT Insider
IDEXX Laboratories’ Earnings Call: Strong Growth Amid Challenges - TipRanks
IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) CEO Compensation Looks Acceptable To Us And Here's Why - simplywall.st
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch
IDEXX Laboratories, Inc. (IDXX) Stock Forecasts - Yahoo Finance
Stifel Adjusts Price Target for Idexx Laboratories (IDXX) Following Q1 Results | IDXX Stock News - GuruFocus
IDEXX Laboratories (IDXX) Surges After Lifting 2025 Outlook on F - GuruFocus
IDEXX Laboratories stock jumps on Q1 beat (IDXX:NASDAQ) - Seeking Alpha
IDEXX Laboratories (IDXX) Reports Strong Start to 2025 with Reve - GuruFocus
Earnings call transcript: IDEXX Labs Q1 2025 EPS beats forecast, stock surges - Investing.com
Idexx Laboratories Inc (IDXX) 財務データ
収益
当期純利益
現金流量
EPS
2.16%
1.96%
大文字化:
|
ボリューム (24 時間):